BACKGROUND: Several mechanisms have been proposed to contribute to cardiac dysfunction in obesity models, such as alterations in calcium (Ca²⁺) handling proteins and β-adrenergic receptors. Nevertheless, the role of these factors in the development of myocardial dysfunction induced by obesity is still not clear. OBJECTIVE: The purpose of this study was to investigate whether obesity induced by hypercaloric diets results in cardiac dysfunction. Furthermore, it was evaluated whether this functional abnormality in obese rats is related to abnormal Ca²⁺ handling and the β-adrenoceptor system. METHODS: Male 30-day-old Wistar rats were fed with standard food (C) and a cycle of five hypercaloric diets (Ob) for 15 weeks. Obesity was defined as increases in body fat percentage in rats. Cardiac function was evaluated by isolated analysis of the left ventricle papillary muscle under basal conditions and after inotropic and lusitropic maneuvers. RESULTS: Compared with the control group, the obese rats had increased body fat and glucose intolerance. The muscles of obese rats developed similar baseline data, but the myocardial responsiveness to post-rest contraction stimulus and increased extracellular Ca²⁺ were compromised. There were no changes in cardiac function between groups after β-adrenergic stimulation. CONCLUSION: Obesity promotes cardiac dysfunction related to changes in intracellular Ca²⁺ handling. This functional damage is probably caused by reduced cardiac sarcoplasmic reticulum Ca²⁺ ATPase (SERCA2) activation via Ca²⁺ calmodulin kinase.
BACKGROUND: Several mechanisms have been proposed to contribute to cardiac dysfunction in obesity models, such as alterations in calcium (Ca²⁺) handling proteins and β-adrenergic receptors. Nevertheless, the role of these factors in the development of myocardial dysfunction induced by obesity is still not clear. OBJECTIVE: The purpose of this study was to investigate whether obesity induced by hypercaloric diets results in cardiac dysfunction. Furthermore, it was evaluated whether this functional abnormality in obeserats is related to abnormal Ca²⁺ handling and the β-adrenoceptor system. METHODS: Male 30-day-old Wistar rats were fed with standard food (C) and a cycle of five hypercaloric diets (Ob) for 15 weeks. Obesity was defined as increases in body fat percentage in rats. Cardiac function was evaluated by isolated analysis of the left ventricle papillary muscle under basal conditions and after inotropic and lusitropic maneuvers. RESULTS: Compared with the control group, the obeserats had increased body fat and glucose intolerance. The muscles of obeserats developed similar baseline data, but the myocardial responsiveness to post-rest contraction stimulus and increased extracellular Ca²⁺ were compromised. There were no changes in cardiac function between groups after β-adrenergic stimulation. CONCLUSION:Obesity promotes cardiac dysfunction related to changes in intracellular Ca²⁺ handling. This functional damage is probably caused by reduced cardiac sarcoplasmic reticulum Ca²⁺ ATPase (SERCA2) activation via Ca²⁺ calmodulin kinase.
Authors: Ana Paula Lima-Leopoldo; André S Leopoldo; Danielle C T da Silva; André F do Nascimento; Dijon H S de Campos; Renata A M Luvizotto; Adriana F de Deus; Paula P Freire; Alessandra Medeiros; Katashi Okoshi; Antonio C Cicogna Journal: J Appl Physiol (1985) Date: 2014-06-26
Authors: Artur Junio Togneri Ferron; Bruno Barcellos Jacobsen; Paula Grippa Sant'Ana; Dijon Henrique Salomé de Campos; Loreta Casquel de Tomasi; Renata de Azevedo Mello Luvizotto; Antonio Carlos Cicogna; André Soares Leopoldo; Ana Paula Lima-Leopoldo Journal: PLoS One Date: 2015-09-21 Impact factor: 3.240
Authors: Fernando Martins; Dijon Henrique Salomé Campos; Luana Urbano Pagan; Paula Felippe Martinez; Katashi Okoshi; Marina Politi Okoshi; Carlos Roberto Padovani; Albert Schiaveto de Souza; Antonio Carlos Cicogna; Silvio Assis de Oliveira-Junior Journal: Arq Bras Cardiol Date: 2015-08-18 Impact factor: 2.000
Authors: Danielle F Vileigas; Adriana F de Deus; Danielle C T da Silva; Loreta C de Tomasi; Dijon H S de Campos; Caroline S Adorni; Scarlet M de Oliveira; Paula G Sant'Ana; Katashi Okoshi; Carlos R Padovani; Antonio C Cicogna Journal: Physiol Rep Date: 2016-09
Authors: Vitor L da Silva; Ana P Lima-Leopoldo; Artur J T Ferron; Jóctan P Cordeiro; Paula P Freire; Dijon H S de Campos; Carlos R Padovani; Mário M Sugizaki; Antonio C Cicogna; André S Leopoldo Journal: Physiol Rep Date: 2017-10-16
Authors: Silvio A Oliveira Junior; Carlos R Padovani; Sergio A Rodrigues; Nilza R Silva; Paula F Martinez; Dijon Hs Campos; Marina P Okoshi; Katashi Okoshi; Maeli Dal-Pai; Antonio C Cicogna Journal: Cardiovasc Diabetol Date: 2013-04-15 Impact factor: 9.951
Authors: Felipe Gonçalves Dos Santos de Sá; Ana Paula Lima-Leopoldo; Bruno Barcellos Jacobsen; Artur Junio Togneri Ferron; Wagner Muller Estevam; Dijon Henrique Salomé Campos; Edson Castardeli; Márcia Regina Holanda da Cunha; Antonio Carlos Cicogna; André Soares Leopoldo Journal: Arq Bras Cardiol Date: 2015-10-27 Impact factor: 2.000
Authors: Silvio A Oliveira-Junior; Paula F Martinez; Danielle M Guizoni; Dijon H S Campos; Tiago Fernandes; Edilamar M Oliveira; Marina P Okoshi; Katashi Okoshi; Carlos R Padovani; Antonio C Cicogna Journal: PLoS One Date: 2014-01-23 Impact factor: 3.240